Welspun Flooring Limited – Trademark Portfolio
Entity Type: 03
Welspun Flooring Limited holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 9 filings in this category. The portfolio also extends into Class 27 (Floor Coverings) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include NY6+, RESILONX, WEL-CORE, SCRAPEGUARD, and HEALTHYFLOOR. The owner is based in Mumbai.
Welspun House, 6th Floor, Kamala City
Senapati Bapat Marg, Lower Parel (W)
Mumbai 400013 , IN
Showing of trademarks Trademarks
Trademark Classifications
Welspun Flooring Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does Welspun Flooring Limited have?
Welspun Flooring Limited has 13 U.S. trademarks filed with the USPTO. Of these, 6 registered, 7 abandoned.
What trademark classes does Welspun Flooring Limited file in?
Welspun Flooring Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 19 (Building Materials), Class 27 (Floor Coverings), Class 37 (Building & Construction). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.
What are Welspun Flooring Limited's most well-known trademarks?
Welspun Flooring Limited's registered trademark portfolio includes well-known marks such as NY6+, RESILONX, WEL-CORE, SCRAPEGUARD, and HEALTHYFLOOR. These are among 6 currently registered trademarks in the portfolio.
What is Welspun Flooring Limited's trademark registration success rate?
Welspun Flooring Limited has a 46% trademark registration rate, with 6 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.